巨噬细胞外泌体源miR-223促进胃癌细胞对奥沙利铂的耐药研究

doi:10.19401/j.cnki.1007-3639.2021.05.002

中国癌症杂志 ›› 2021, Vol. 31 ›› Issue (5): 368-378.doi: 10.19401/j.cnki.1007-3639.2021.05.002

巨噬细胞外泌体源miR-223促进胃癌细胞对奥沙利铂的耐药研究

郑培明 ¹，李俊蒙 ²，张　鹏 ² ，高　岚¹

1. 河南省人民医院检验科，河南郑州 450003 ；
2. 河南省人民医院胃肠外科，河南郑州 450003

出版日期:2021-05-30 发布日期:2021-05-31
通信作者: 高　岚 E-mail: gaolan8@126.com
基金资助:
国家自然科学基金青年项目（81802094）。

Exosomal transfer of macrophage-derived miR-223 confers oxaliplatin resistance in gastric cancer

ZHENG Peiming ¹ , LI Junmeng ² , ZHANG Peng ² , GAO Lan ¹#br#

1. Department of Clinical Laboratory, Henan Provincial People’s Hospital, Zhengzhou 450003, Henan Province, China; 2. Department of Gastrointestinal Surgery, Henan Provincial People’s Hospital, Zhengzhou 450003, Henan Province, China

Published:2021-05-30 Online:2021-05-31
Contact: GAO Lan E-mail: gaolan8@126.com

摘要/Abstract

摘要： 背景与目的：化疗耐药是导致胃癌患者预后不良的重要因素，阐明胃癌细胞化疗耐药的机制有助于为临床治疗提供新思路，具有重要的现实意义。探讨巨噬细胞外泌体源miR-223对胃癌细胞奥沙利铂化疗敏感性的影响及作用机制。方法：将购自中国科学院典型培养物保藏委员会细胞库/中国科学院上海生命科学研究院细胞资源中心的胃癌细胞与巨噬细胞及其来源外泌体共培养，检测miR-223的表达水平并观察其对奥沙利铂的化疗敏感性。采用荧光显微镜观察巨噬细胞是否通过外泌体传递miR-223至胃癌细胞。采用细胞计数试剂盒-8（cell counting kit-8，CCK-8）、细胞凋亡实验观察巨噬细胞外泌体源miR-223对胃癌细胞奥沙利铂化疗敏感性的影响。采用实时荧光定量聚合酶链反应（real-time fluorescence quantitative polymerase chain reaction，RTFQ-PCR）检测胃癌患者外周血外泌体源miR-223的表达水平，分析其与奥沙利铂耐药的关系。结果：巨噬细胞及其外泌体与胃癌细胞共培养后，胃癌细胞对奥沙利铂化疗的敏感性降低，半数抑制浓度（half inhibition concentration，IC ₅₀ ）明显升高；同时miR-223相对表达量明显增加。采用荧光显微镜观察发现，巨噬细胞通过外泌体传递miR-223至胃癌细胞。巨噬细胞外泌体源miR-223通过调控FBXW7增强胃癌细胞抗凋亡能力，促进其对奥沙利铂的耐药。奥沙利铂耐药胃癌患者外周血外泌体miR-223的表达水平显著升高。结论：巨噬细胞通过外泌体传递miR-223增强胃癌细胞对奥沙利铂的耐药，外周血外泌体源miR-223有望成为胃癌患者化疗耐药的监测指标。

关键词: 巨噬细胞, 胃癌, 外泌体, miR-223, 奥沙利铂, 耐药

Abstract: Background and purpose: Chemotherapy resistance is an important factor resulting in poor prognosis of gastric cancer patients. The elucidation of molecular mechanisms underlying chemoresistance is helpful to provide new therapeutic strategy, which has important practical significance. This study aimed to investigate the effect ofexosomal miR-223 derived from macrophage on oxaliplatin chemosensitivity of gastric cancer cells and its mechanism. Methods: Gastric cancer cells purchased from National Collection of Authenticated Cell Cultures were co-cultured with macrophages or macrophage-derived exosomes. The miR-223 expression was detected by real-time fluorescence quantitative polymerase chain reaction (RTFQ-PCR). The transfer of miR-223 through internalization of exosomes was observed by immunofluorescence. Macrophages were transfected with a miR-223 inhibitor or negative control. Cell counting kit-8 (CCK-8) and apoptosis assay were employed to explore the effect of macrophage-derived exosomes on the oxaliplatin chemosensitivity of gastric cancer cells. The clinical relationship between the expression of exosomal miR-223 in plasma and oxaliplatin resistance in gastric cancer patients was also explored. Results: The chemosensitivity of gastric cancer cells to oxaliplatin decreased, while half inhibition concentration (IC ₅₀ ) increased significantly when co-cultured with macrophages or macrophage-derived exosomes. The expression level of miR-223 was significantly increased, and exosomal transfer of miR-223 was observed by immunofluorescence. Functional studies revealed that exosomal miR-223 derived from macrophages promoted oxaliplatin resistance in gastric cancer cells by inhibiting FBXW7. Clinically, the high expression of plasma exosomal miR-223 was highly linked with oxaliplatin resistance in gastric cancer patients. Conclusion: The exosomal transfer of macrophage-derived miR-223 conferred oxaliplatin resistance in gastric cancer cells, and these results indicated that circulating exosomal miR-223 may be a useful monitoring indicator for oxaliplatin resistance in gastric cancer treatment.

Key words: Macrophage, Gastric cancer, Exosome, miR-223, Oxaliplatin, Chemoresistance

郑培明, 李俊蒙, 张　鹏, 高　岚 . 巨噬细胞外泌体源miR-223促进胃癌细胞对奥沙利铂的耐药研究[J]. 中国癌症杂志, 2021, 31(5): 368-378.

ZHENG Peiming , LI Junmeng , ZHANG Peng , GAO Lan . Exosomal transfer of macrophage-derived miR-223 confers oxaliplatin resistance in gastric cancer[J]. China Oncology, 2021, 31(5): 368-378.

[1]	张学成, 关晓辉 . Circ_0007142吸附miR-647调控CCR8基因促进胃癌细胞的上皮-间质转化和侵袭[J]. 中国癌症杂志, 2021, 31(8): 714-724.
[2]	龚　超, 陈　魁, 章德昆, 谢径峰, 吴芳华, 黄玉钿, 薛玉钦, 王力群 . 基于加权基因共表达网络分析构建胃癌转移预测模型[J]. 中国癌症杂志, 2021, 31(8): 746-753.
[3]	朱逸晖, 李　婷, 胡夕春. Trastuzumab deruxtecan的临床研究进展及展望——HER2耐药患者的新希望[J]. 中国癌症杂志, 2021, 31(8): 754-761.
[4]	马维东, 王彤彤, 朱启航, 杨海鸥, 林　丹. 外泌体中circ_0044366调控肿瘤相关成纤维细胞MMP2的表达促进结直肠癌转移的机制研究[J]. 中国癌症杂志, 2021, 31(5): 397-407.
[5]	李瑞晓, 唐启胜, 马善金, 张　波, 李雪莲, 张志明 . NDRG2通过抑制Bcl-2表达增加膀胱癌细胞对顺铂的敏感性[J]. 中国癌症杂志, 2021, 31(4): 263-267.
[6]	刘　斌, 郑鹏远, 米　阳, 任飞飞, 高　爽, 刘　传, 李发展 . LRP8在胃癌中的表达及其在胃癌发生过程中的作用[J]. 中国癌症杂志, 2021, 31(4): 285-293.
[7]	汪　明, 曹　晖. 晚期胃肠间质瘤药物治疗进展[J]. 中国癌症杂志, 2021, 31(2): 90-99.
[8]	丁平安, 张志栋, 杨沛刚, 林叶成, 田　园, 徐校胜, 吴　娟, 刘　颖, 郭洪海, 刘　洋, 王　冬, 檀碧波, 李　勇, 赵　群 . 胃癌脑膜转移的临床病理学特征及预后分析[J]. 中国癌症杂志, 2021, 31(2): 126-135.
[9]	李芷君, 徐兵河. 乳腺癌芳香化酶抑制剂耐药的研究进展[J]. 中国癌症杂志, 2021, 31(2): 81-89.
[10]	贺国洋, 陈庆庆, 邓美静, 王高翔, 王贝玺, 王永霞, 李　巍, 千新来, 朱会芳, . DIAPH3对胃癌细胞增殖、迁移和侵袭的影响及分子机制[J]. 中国癌症杂志, 2021, 31(12): 1174-1184.
[11]	武鸿文, 梅　艳, 王　乔, 袁　佳, 赵立威. 血清MIP-1α、S-TK1对于甲状腺癌术后放射性 ¹³¹ I治疗效果评估的临床价值[J]. 中国癌症杂志, 2021, 31(11): 1088-1095.
[12]	徐亦天, 黄　陈. 非血液来源液体活检在胃癌早期诊断中的研究进展[J]. 中国癌症杂志, 2021, 31(10): 936-943.
[13]	叶星明, 王　淋, 贾　静, 吴秀凤, 陈　颖 . miR-375靶向YAP1调控上皮-间质转化参与乳腺癌细胞曲妥珠单抗的耐药[J]. 中国癌症杂志, 2021, 31(1): 27-34.
[14]	程　玉, 郝美玲, 薛　晶, 齐洁敏 . 节律因子BMAL1通过SHH信号转导通路影响胃癌MGC-803细胞的增殖[J]. 中国癌症杂志, 2020, 30(9): 661-666.
[15]	潘星昊, 刘明斌, 张晓燕, 徐建青. 外泌体作为靶向治疗载体的研究进展[J]. 中国癌症杂志, 2020, 30(9): 701-706.

巨噬细胞外泌体源miR-223促进胃癌细胞对奥沙利铂的耐药研究

Exosomal transfer of macrophage-derived miR-223 confers oxaliplatin resistance in gastric cancer

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价